Oncolytics Biotech Inc. Share
Oncolytics Biotech Inc. Share price
Key metrics
| Market capitalization | $75.49m |
| Enterprise Value | $54.44m |
| PER (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 4.42 |
| Turnover (TTM) Turnover | $0.00 |
| EBIT (operating result TTM) EBIT | $-26.54m |
| Free cash flow (TTM) Free cash flow | $-20.67m |
| Cash position | $21.88m |
Is Oncolytics Biotech Inc. a top scorer stock according to the dividend, high growth investing or Leverman strategy?
As a free StocksGuide basic user, you can view the scores for all 6,954 shares worldwide.
Oncolytics Biotech Inc. Share analysis
Analyst opinions
7 Analysts have issued a Oncolytics Biotech Inc. forecast:
Analyst opinions
7 Analysts have issued a Oncolytics Biotech Inc. forecast:
Financial data from Oncolytics Biotech Inc.
| Dec '23 |
+/-
%
|
||
| Turnover | - - |
-
|
|
| Gross income | -0.30 -0.30 |
0%
0%
|
|
| EBITDA | -25 -25 |
21%
21%
|
EBIT (operating result) EBIT | -25 -25 |
21%
21%
|
| Net profit | -21 -21 |
8%
8%
|
|
Figures in millions USD.
Don't miss a thing! We will send you all news about the Oncolytics Biotech Inc. share directly to your mailbox free of charge.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
Oncolytics Biotech Inc. Share News
Company profile
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.
| Head office | Canada |
| CEO | Wayne Pisano |
| Employees | 27 |
| Founded | 1998 |
| Website | www.oncolyticsbiotech.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
